Detalhe da pesquisa
1.
GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15.
Gynecol Oncol
; 185: 8-16, 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342006
2.
The senescence-associated secretory phenotype in ovarian cancer dissemination.
Am J Physiol Cell Physiol
; 323(1): C125-C132, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35584328
3.
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Nature
; 532(7598): 250-4, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27042933
4.
EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer.
EMBO J
; 34(23): 2953-70, 2015 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26492917
5.
Simultaneous isotope dilution quantification and metabolic tracing of deoxyribonucleotides by liquid chromatography high resolution mass spectrometry.
Anal Biochem
; 568: 65-72, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30605633
6.
PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion.
Proc Natl Acad Sci U S A
; 112(28): 8638-43, 2015 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26124089
7.
Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Nature
; 537(7619): 254, 2016 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27383789
8.
CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR.
Cancer Gene Ther
; 31(2): 300-310, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030811
9.
GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15.
bioRxiv
; 2024 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38352432
10.
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression.
Cancer Res Commun
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626341
11.
Alternative splice variants of the mitochondrial fission protein DNM1L/Drp1 regulate mitochondrial dynamics and tumor progression in ovarian cancer.
bioRxiv
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37790404
12.
αKG-mediated carnitine synthesis promotes homologous recombination via histone acetylation.
bioRxiv
; 2024 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38370789
13.
Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote Resistance.
Cancer Immunol Res
; 11(4): 401-404, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36826438
14.
Tumor-Associated Macrophages Expand Chemoresistant, Ovarian Cancer Stem-Like Cells.
bioRxiv
; 2023 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37503008
15.
ATR promotes mTORC1 activation via de novo cholesterol synthesis in p16-low cancer cells.
bioRxiv
; 2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961201
16.
ATM inhibition drives metabolic adaptation via induction of macropinocytosis.
J Cell Biol
; 222(1)2023 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399181
17.
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression.
bioRxiv
; 2023 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37503050
18.
ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells.
Breast Cancer Res Treat
; 132(1): 109-19, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21559822
19.
Ovarian cancer: how can resistance to chemotherapy be tackled?
Future Oncol
; 13(30): 2737-2739, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29182383
20.
Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/ß expression.
Cell Rep
; 40(12): 111371, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130512